New Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne
- PMID: 38306144
- DOI: 10.36849/JDD.8137
New Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne
Abstract
Acne Vulgaris (AV) is a prominent skin disease commonly affecting teenagers. It often persists into adulthood and is associated with adverse physical and psychosocial impacts. The pathophysiology of AV is conventionally correlated with 4 factors within and around the pilosebaceous unit: increased sebum production, follicular hyperkeratinization, Cutibacterium acnes proliferation, and localized immune responses. As such, conventional therapeutic approaches for AV have primarily focused on these factors. In addition to this primarily localized pathophysiology, there is a progressively emerging body of evidence indicating that underlying systemic factors contributing to a generalized immuno-inflammatory response can contribute to or exacerbate AV. In this article, we introduce and provide the supporting data, for 6 patient-centric systems that may be implicated in the development of AV: psycho-emotional stress, diet and metabolism, dysbiosis of the gut and skin microbiome, hormonal fluctuations, oxidative stress, and immune response. Identifying these pathways and their contributions in a patient-centric approach may provide expanded therapeutic opportunities for treating patients with AV. J Drugs Dermatol. 2024;23(2):90-96. doi:10.36849/JDD.8137.
Similar articles
-
A Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical.J Drugs Dermatol. 2024 Mar 1;23(3):160-167. doi: 10.36849/jdd.8138. J Drugs Dermatol. 2024. PMID: 38443131
-
The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management.J Dermatolog Treat. 2024 Dec;35(1):2296855. doi: 10.1080/09546634.2023.2296855. Epub 2023 Dec 26. J Dermatolog Treat. 2024. PMID: 38146664 Review.
-
The increasing importance of the gut microbiome in acne vulgaris.Folia Microbiol (Praha). 2022 Dec;67(6):825-835. doi: 10.1007/s12223-022-00982-5. Epub 2022 Jun 16. Folia Microbiol (Praha). 2022. PMID: 35711021 Review.
-
Skin barrier and microbiome in acne.Arch Dermatol Res. 2018 Apr;310(3):181-185. doi: 10.1007/s00403-017-1795-3. Epub 2017 Nov 17. Arch Dermatol Res. 2018. PMID: 29147769 Review.
-
The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris.J Dermatolog Treat. 2024 Dec;35(1):2298878. doi: 10.1080/09546634.2023.2298878. Epub 2024 Jan 8. J Dermatolog Treat. 2024. PMID: 38192024 Review.
Cited by
-
Deficit of Omega-3 Fatty Acids in Acne Patients-A Cross-Sectional Pilot Study in a German Cohort.Life (Basel). 2024 Apr 17;14(4):519. doi: 10.3390/life14040519. Life (Basel). 2024. PMID: 38672789 Free PMC article.
-
A 12-week, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of a Nutraceutical Supplement for Mild to Moderate Non-cystic Acne in Young Adults.J Clin Aesthet Dermatol. 2024 Nov;17(11):24-30. J Clin Aesthet Dermatol. 2024. PMID: 39758223 Free PMC article.
-
A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial for the Efficacy and Safety of a Novel Nutraceutical for Mild-to-Moderate Acne.J Cosmet Dermatol. 2025 May;24(5):e70220. doi: 10.1111/jocd.70220. J Cosmet Dermatol. 2025. PMID: 40321085 Free PMC article. Clinical Trial.
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair.J Cosmet Dermatol. 2025 Jan;24(1):e16778. doi: 10.1111/jocd.16778. J Cosmet Dermatol. 2025. PMID: 39757794 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials